Skip to content

Insider · CIK 0001958487

Eastling Thomas Wilson

Reports to the SEC for 1 company · SAN DIEGO, CA

Transactions

13

Companies

1

Filings

5

CIK

0001958487

Forms 4 and 5

Insider transactions

13 trades
DateCompanyValue
2026-05-04GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2026-05-04GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2026-05-04GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2026-05-04GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2026-05-04GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2026-05-04GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2026-05-04GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2025-06-04GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2025-04-16GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion+$104K
2025-04-16GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion—
2024-08-14GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2023-10-31GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—
2023-10-31GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award—

Recent filings

5

Companies

1

Address

C/O GYRE THERAPEUTICS, INC. 12770 HIGH BLUFF DRIVE, SUITE 150

SAN DIEGO, CA, 92130